Solutions > Computational Lead Generation and Optimization Across Modalities
Computational Lead Generation and Optimization Across Modalities
Many modalities are emerging that necessitate the formation of models connecting modality properties with their structure. Screening of therapeutic antibodies, cell therapies, and nucleic-acid-based therapeutics often require bespoke methods and tools with little commercial support. bPrescient can help, with data-driven, multi-parametric optimization for molecule performance. We provide a quantitative approach to structure-activity relationship for small molecules, antibodies, mRNA, and antisense oligonucleotides.
